Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy

被引：0
|
作者：
Derbala, Mohamed H.
Hajjar, Joud
Stephen, Bettzy
Gurses, Serdar A.
Kwiatkowski, Evan
Budde, Petra
Zucht, Hans-Dieter
Brautigam, Manuel
Schubert, Ann-Sophie
Ahangarianabhari, Behnaz
Rodriguez, Enedelia
Gouda, Mohamed
Castillo, Lilibeth
Zarifa, Abdulrazzak
How, Jeffrey A.
Moyers, Justin T.
Hong, David S.
Meric-Bernstam, Funda
Naing, Aung
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5141
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells
    Gazzano, Marianne
    Parizot, Christophe
    Psimaras, Dimitri
    Vozy, Aurore
    Baron, Marine
    Abbar, Baptiste
    Fallet, Vincent
    Litvinova, Elena
    Canellas, Anthony
    Birzu, Cristina
    Pourcher, Valerie
    Touat, Mehdi
    Weiss, Nicolas
    Demeret, Sophie
    Roos-Weil, Damien
    Spano, Jean-Philippe
    Lebbe, Celeste
    Salem, Joe-Elie
    Cadranel, Jacques
    Hervier, Baptiste
    Gorochov, Guy
    Guihot, Amelie
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies
    Rogado, Jacobo
    Romero-Laorden, Nuria
    Miguel Sanchez-Torres, Jose
    Maria Ramos-Levi, Ana
    Pacheco-Barcia, Vilma
    Isabel Ballesteros, Ana
    Arranz, Reyes
    Lorenzo, Alicia
    Gullon, Pedro
    Garrido, Ana
    Serra Lopez-Matencio, Jose Maria
    Donnay, Olga
    Adrados, Magdalena
    Costas, Pablo
    Aspa, Javier
    Alfranca, Arantzazu
    Mondejar, Rebeca
    Colomer, Ramon
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [33] Evaluation of tumorous LCP1 and ADPGK as predictive biomarker for immune-related adverse events in bone and soft tissue sarcomas treated with anti-PD-1 and anti-PD-L1 antibodies
    Zhang, Qing
    Wang, Zhe
    Zeng, Xueqin
    Ding, Yi
    Wang, Chen
    BMC CANCER, 2025, 25 (01)
  • [34] Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
    Rogado Revuelta, Jacobo
    Romero-Laorden, Nuria
    Sanchez Torres, Jose Miguel
    Pacheco-Barcia, Vilma
    Ballesteros, Anabel
    Maria Ramos-Levi, Ana
    Arranz, Reyes
    Lorenzo, Alicia
    Gullon, Pedro
    Garrido Garcia, Ana
    Maria Serra, Jose
    Donnay, Olga
    Adrados, Magdalena
    Costas, Pablo
    Aspa, Javier
    Alfranca, Arantza
    Fenor De la Maza, Maria Dolores
    Mondejar, Rebeca
    Colomer, Ramon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Aude, C.
    Ghosh, N.
    Jannat-Khah, D.
    Chan, K. K.
    Postow, M.
    Larman, H.
    Bass, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
  • [36] Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients
    Rogado, J.
    Romero Laorden, N.
    Sanchez Torres, J. M.
    Ballesteros Garcia, A. I.
    Pacheco-Barcia, V. E.
    Arranz, R.
    Mondejar Solis, R.
    Gullon, P.
    Lorenzo, A.
    Colomer Bosch, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [38] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [39] Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies
    Oya, Kazumasa
    Nakamura, Yoshiyuki
    Shen, Larina Tzu-Wei
    Ishizuki, Shoichiro
    Matsusaka, Satoshi
    Fujisawa, Yasuhiro
    JOURNAL OF DERMATOLOGY, 2024, 51 (06): : 807 - 815
  • [40] Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment
    Kim, Kyung Hwan
    Hur, Joon Young
    Cho, Jinhyun
    Ku, Bo Mi
    Koh, Jiae
    Koh, June Young
    Sun, Jong-Mu
    Lee, Se-Noon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    Shin, Eui-Cheol
    ONCOIMMUNOLOGY, 2020, 9 (01):
12345